nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB10—hematopoietic system—malaria	0.0284	0.0743	CbGeAlD
Carfilzomib—PSMB10—digestive system—malaria	0.0198	0.0517	CbGeAlD
Carfilzomib—PSMB8—saliva-secreting gland—malaria	0.0192	0.0502	CbGeAlD
Carfilzomib—PSMB10—blood—malaria	0.0188	0.0492	CbGeAlD
Carfilzomib—PSMB5—saliva-secreting gland—malaria	0.017	0.0443	CbGeAlD
Carfilzomib—PSMB1—saliva-secreting gland—malaria	0.0148	0.0388	CbGeAlD
Carfilzomib—PSMB10—liver—malaria	0.0147	0.0385	CbGeAlD
Carfilzomib—PSMB2—saliva-secreting gland—malaria	0.0145	0.0378	CbGeAlD
Carfilzomib—PSMB1—hematopoietic system—malaria	0.0141	0.037	CbGeAlD
Carfilzomib—PSMB2—hematopoietic system—malaria	0.0138	0.0361	CbGeAlD
Carfilzomib—Bacterial infection—Clindamycin—malaria	0.0136	0.0383	CcSEcCtD
Carfilzomib—PSMB8—blood—malaria	0.0121	0.0317	CbGeAlD
Carfilzomib—PSMB8—bone marrow—malaria	0.0117	0.0307	CbGeAlD
Carfilzomib—PSMB10—brain—malaria	0.0117	0.0306	CbGeAlD
Carfilzomib—PSMB1—kidney—malaria	0.0116	0.0303	CbGeAlD
Carfilzomib—Neuritis—Sulfadiazine—malaria	0.0113	0.0318	CcSEcCtD
Carfilzomib—PSMB2—kidney—malaria	0.0113	0.0296	CbGeAlD
Carfilzomib—PSMB5—blood—malaria	0.0107	0.028	CbGeAlD
Carfilzomib—PSMB5—bone marrow—malaria	0.0104	0.0271	CbGeAlD
Carfilzomib—PSMB1—digestive system—malaria	0.00984	0.0257	CbGeAlD
Carfilzomib—PSMB2—digestive system—malaria	0.0096	0.0251	CbGeAlD
Carfilzomib—PSMB8—liver—malaria	0.00949	0.0248	CbGeAlD
Carfilzomib—PSMB1—blood—malaria	0.00937	0.0245	CbGeAlD
Carfilzomib—PSMB2—blood—malaria	0.00915	0.0239	CbGeAlD
Carfilzomib—PSMB1—bone marrow—malaria	0.00907	0.0237	CbGeAlD
Carfilzomib—PSMB2—bone marrow—malaria	0.00885	0.0231	CbGeAlD
Carfilzomib—PSMB5—liver—malaria	0.00839	0.0219	CbGeAlD
Carfilzomib—PSMB8—brain—malaria	0.00753	0.0197	CbGeAlD
Carfilzomib—Sepsis—Sulfadiazine—malaria	0.00734	0.0206	CcSEcCtD
Carfilzomib—PSMB1—liver—malaria	0.00733	0.0192	CbGeAlD
Carfilzomib—PSMB2—liver—malaria	0.00715	0.0187	CbGeAlD
Carfilzomib—PSMB5—brain—malaria	0.00665	0.0174	CbGeAlD
Carfilzomib—Leukopenia—Pyrimethamine—malaria	0.0064	0.018	CcSEcCtD
Carfilzomib—PSMB1—brain—malaria	0.00582	0.0152	CbGeAlD
Carfilzomib—Thrombocytopenia—Pyrimethamine—malaria	0.00571	0.0161	CcSEcCtD
Carfilzomib—PSMB2—brain—malaria	0.00567	0.0148	CbGeAlD
Carfilzomib—Anorexia—Pyrimethamine—malaria	0.00556	0.0156	CcSEcCtD
Carfilzomib—Decreased appetite—Pyrimethamine—malaria	0.00507	0.0143	CcSEcCtD
Carfilzomib—Cough—Proguanil—malaria	0.00486	0.0137	CcSEcCtD
Carfilzomib—Renal failure acute—Quinidine—malaria	0.00486	0.0137	CcSEcCtD
Carfilzomib—Renal failure acute—Quinine—malaria	0.00486	0.0137	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Sulfadiazine—malaria	0.00464	0.013	CcSEcCtD
Carfilzomib—Renal failure acute—Quinidine barbiturate—malaria	0.00438	0.0123	CcSEcCtD
Carfilzomib—Cardiac arrest—Clindamycin—malaria	0.00435	0.0122	CcSEcCtD
Carfilzomib—Anorexia—Proguanil—malaria	0.00433	0.0122	CcSEcCtD
Carfilzomib—Cardiac arrest—Quinidine—malaria	0.00426	0.012	CcSEcCtD
Carfilzomib—Cardiac arrest—Quinine—malaria	0.00426	0.012	CcSEcCtD
Carfilzomib—Decreased appetite—Proguanil—malaria	0.00395	0.0111	CcSEcCtD
Carfilzomib—Cardiac arrest—Quinidine barbiturate—malaria	0.00385	0.0108	CcSEcCtD
Carfilzomib—ABCB1—blood plasma—malaria	0.00381	0.00997	CbGeAlD
Carfilzomib—Chills—Sulfadiazine—malaria	0.00381	0.0107	CcSEcCtD
Carfilzomib—Vomiting—Pyrimethamine—malaria	0.00371	0.0104	CcSEcCtD
Carfilzomib—Neutropenia—Clindamycin—malaria	0.00369	0.0104	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Clindamycin—malaria	0.00367	0.0103	CcSEcCtD
Carfilzomib—Neutropenia—Quinine—malaria	0.00362	0.0102	CcSEcCtD
Carfilzomib—Neutropenia—Quinidine—malaria	0.00362	0.0102	CcSEcCtD
Carfilzomib—Body temperature increased—Proguanil—malaria	0.00359	0.0101	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Dapsone—malaria	0.00357	0.01	CcSEcCtD
Carfilzomib—Renal failure—Quinine—malaria	0.0034	0.00955	CcSEcCtD
Carfilzomib—Renal failure—Quinidine—malaria	0.0034	0.00955	CcSEcCtD
Carfilzomib—Leukopenia—Sulfadiazine—malaria	0.00331	0.0093	CcSEcCtD
Carfilzomib—Neutropenia—Quinidine barbiturate—malaria	0.00327	0.00919	CcSEcCtD
Carfilzomib—Arthralgia—Sulfadiazine—malaria	0.00315	0.00885	CcSEcCtD
Carfilzomib—Diarrhoea—Proguanil—malaria	0.00311	0.00874	CcSEcCtD
Carfilzomib—Renal failure—Quinidine barbiturate—malaria	0.00307	0.00862	CcSEcCtD
Carfilzomib—Thrombocytopenia—Sulfadiazine—malaria	0.00295	0.0083	CcSEcCtD
Carfilzomib—Vomiting—Proguanil—malaria	0.00289	0.00812	CcSEcCtD
Carfilzomib—Cardiac disorder—Quinine—malaria	0.00288	0.00809	CcSEcCtD
Carfilzomib—Cardiac disorder—Quinidine—malaria	0.00288	0.00809	CcSEcCtD
Carfilzomib—Anorexia—Sulfadiazine—malaria	0.00288	0.00808	CcSEcCtD
Carfilzomib—Headache—Proguanil—malaria	0.00285	0.008	CcSEcCtD
Carfilzomib—Chills—Quinidine—malaria	0.00278	0.00783	CcSEcCtD
Carfilzomib—Chills—Quinine—malaria	0.00278	0.00783	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00275	0.00773	CcSEcCtD
Carfilzomib—Insomnia—Sulfadiazine—malaria	0.00273	0.00767	CcSEcCtD
Carfilzomib—Nausea—Proguanil—malaria	0.0027	0.00759	CcSEcCtD
Carfilzomib—Back pain—Clindamycin—malaria	0.00266	0.00749	CcSEcCtD
Carfilzomib—Muscle spasms—Clindamycin—malaria	0.00265	0.00744	CcSEcCtD
Carfilzomib—Decreased appetite—Sulfadiazine—malaria	0.00262	0.00737	CcSEcCtD
Carfilzomib—Cardiac disorder—Quinidine barbiturate—malaria	0.0026	0.0073	CcSEcCtD
Carfilzomib—Anaemia—Clindamycin—malaria	0.00254	0.00715	CcSEcCtD
Carfilzomib—Chills—Quinidine barbiturate—malaria	0.00251	0.00706	CcSEcCtD
Carfilzomib—Cough—Dapsone—malaria	0.00248	0.00698	CcSEcCtD
Carfilzomib—Leukopenia—Clindamycin—malaria	0.00246	0.00693	CcSEcCtD
Carfilzomib—Leukopenia—Quinidine—malaria	0.00242	0.0068	CcSEcCtD
Carfilzomib—Leukopenia—Quinine—malaria	0.00242	0.0068	CcSEcCtD
Carfilzomib—Body temperature increased—Sulfadiazine—malaria	0.00238	0.0067	CcSEcCtD
Carfilzomib—Hypertension—Clindamycin—malaria	0.00238	0.00668	CcSEcCtD
Carfilzomib—Back pain—Pentoxifylline—malaria	0.00235	0.00662	CcSEcCtD
Carfilzomib—Muscle spasms—Pentoxifylline—malaria	0.00234	0.00658	CcSEcCtD
Carfilzomib—Anaemia—Pentoxifylline—malaria	0.00225	0.00632	CcSEcCtD
Carfilzomib—Thrombocytopenia—Clindamycin—malaria	0.0022	0.00618	CcSEcCtD
Carfilzomib—Leukopenia—Quinidine barbiturate—malaria	0.00218	0.00613	CcSEcCtD
Carfilzomib—Leukopenia—Pentoxifylline—malaria	0.00218	0.00612	CcSEcCtD
Carfilzomib—Thrombocytopenia—Quinine—malaria	0.00216	0.00607	CcSEcCtD
Carfilzomib—Thrombocytopenia—Quinidine—malaria	0.00216	0.00607	CcSEcCtD
Carfilzomib—ABCB1—hematopoietic system—malaria	0.00211	0.00551	CbGeAlD
Carfilzomib—Anorexia—Quinine—malaria	0.0021	0.00591	CcSEcCtD
Carfilzomib—Anorexia—Quinidine—malaria	0.0021	0.00591	CcSEcCtD
Carfilzomib—Insomnia—Dapsone—malaria	0.0021	0.00591	CcSEcCtD
Carfilzomib—Hypertension—Pentoxifylline—malaria	0.0021	0.0059	CcSEcCtD
Carfilzomib—Arthralgia—Quinidine barbiturate—malaria	0.00207	0.00583	CcSEcCtD
Carfilzomib—Diarrhoea—Sulfadiazine—malaria	0.00206	0.0058	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Quinidine—malaria	0.00201	0.00564	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Quinine—malaria	0.00201	0.00564	CcSEcCtD
Carfilzomib—Dyspnoea—Clindamycin—malaria	0.002	0.00563	CcSEcCtD
Carfilzomib—Infection—Pentoxifylline—malaria	0.00197	0.00555	CcSEcCtD
Carfilzomib—Dyspnoea—Quinine—malaria	0.00196	0.00552	CcSEcCtD
Carfilzomib—Dyspnoea—Quinidine—malaria	0.00196	0.00552	CcSEcCtD
Carfilzomib—Thrombocytopenia—Quinidine barbiturate—malaria	0.00195	0.00547	CcSEcCtD
Carfilzomib—Thrombocytopenia—Pentoxifylline—malaria	0.00194	0.00547	CcSEcCtD
Carfilzomib—Fatigue—Clindamycin—malaria	0.00194	0.00545	CcSEcCtD
Carfilzomib—Pain—Clindamycin—malaria	0.00192	0.0054	CcSEcCtD
Carfilzomib—Constipation—Clindamycin—malaria	0.00192	0.0054	CcSEcCtD
Carfilzomib—Vomiting—Sulfadiazine—malaria	0.00192	0.00539	CcSEcCtD
Carfilzomib—Decreased appetite—Quinidine—malaria	0.00192	0.00539	CcSEcCtD
Carfilzomib—Decreased appetite—Quinine—malaria	0.00192	0.00539	CcSEcCtD
Carfilzomib—Anorexia—Quinidine barbiturate—malaria	0.0019	0.00533	CcSEcCtD
Carfilzomib—Anorexia—Pentoxifylline—malaria	0.00189	0.00532	CcSEcCtD
Carfilzomib—Headache—Sulfadiazine—malaria	0.00189	0.00531	CcSEcCtD
Carfilzomib—Body temperature increased—Dapsone—malaria	0.00184	0.00516	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.00181	0.00509	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.00181	0.00509	CcSEcCtD
Carfilzomib—Insomnia—Pentoxifylline—malaria	0.0018	0.00505	CcSEcCtD
Carfilzomib—Nausea—Sulfadiazine—malaria	0.00179	0.00504	CcSEcCtD
Carfilzomib—Body temperature increased—Clindamycin—malaria	0.00178	0.00499	CcSEcCtD
Carfilzomib—Dyspnoea—Quinidine barbiturate—malaria	0.00177	0.00499	CcSEcCtD
Carfilzomib—Dyspnoea—Pentoxifylline—malaria	0.00177	0.00498	CcSEcCtD
Carfilzomib—Body temperature increased—Quinidine—malaria	0.00174	0.0049	CcSEcCtD
Carfilzomib—Body temperature increased—Quinine—malaria	0.00174	0.0049	CcSEcCtD
Carfilzomib—Decreased appetite—Quinidine barbiturate—malaria	0.00173	0.00486	CcSEcCtD
Carfilzomib—ABCB1—kidney—malaria	0.00173	0.00452	CbGeAlD
Carfilzomib—Decreased appetite—Pentoxifylline—malaria	0.00173	0.00485	CcSEcCtD
Carfilzomib—Pain—Quinidine barbiturate—malaria	0.0017	0.00478	CcSEcCtD
Carfilzomib—Constipation—Quinidine barbiturate—malaria	0.0017	0.00478	CcSEcCtD
Carfilzomib—Constipation—Pentoxifylline—malaria	0.0017	0.00477	CcSEcCtD
Carfilzomib—Asthenia—Clindamycin—malaria	0.00161	0.00453	CcSEcCtD
Carfilzomib—Asthenia—Quinine—malaria	0.00158	0.00445	CcSEcCtD
Carfilzomib—Asthenia—Quinidine—malaria	0.00158	0.00445	CcSEcCtD
Carfilzomib—Body temperature increased—Quinidine barbiturate—malaria	0.00157	0.00442	CcSEcCtD
Carfilzomib—Body temperature increased—Pentoxifylline—malaria	0.00157	0.00441	CcSEcCtD
Carfilzomib—Diarrhoea—Clindamycin—malaria	0.00154	0.00432	CcSEcCtD
Carfilzomib—Diarrhoea—Quinidine—malaria	0.00151	0.00424	CcSEcCtD
Carfilzomib—Diarrhoea—Quinine—malaria	0.00151	0.00424	CcSEcCtD
Carfilzomib—Dizziness—Clindamycin—malaria	0.00149	0.00418	CcSEcCtD
Carfilzomib—Vomiting—Dapsone—malaria	0.00148	0.00415	CcSEcCtD
Carfilzomib—ABCB1—digestive system—malaria	0.00147	0.00383	CbGeAlD
Carfilzomib—Dizziness—Quinidine—malaria	0.00146	0.0041	CcSEcCtD
Carfilzomib—Dizziness—Quinine—malaria	0.00146	0.0041	CcSEcCtD
Carfilzomib—Headache—Dapsone—malaria	0.00146	0.00409	CcSEcCtD
Carfilzomib—Vomiting—Clindamycin—malaria	0.00143	0.00402	CcSEcCtD
Carfilzomib—Asthenia—Quinidine barbiturate—malaria	0.00143	0.00401	CcSEcCtD
Carfilzomib—Asthenia—Pentoxifylline—malaria	0.00142	0.004	CcSEcCtD
Carfilzomib—Headache—Clindamycin—malaria	0.00141	0.00396	CcSEcCtD
Carfilzomib—Vomiting—Quinine—malaria	0.0014	0.00394	CcSEcCtD
Carfilzomib—Vomiting—Quinidine—malaria	0.0014	0.00394	CcSEcCtD
Carfilzomib—ABCB1—blood—malaria	0.0014	0.00365	CbGeAlD
Carfilzomib—Headache—Quinine—malaria	0.00138	0.00388	CcSEcCtD
Carfilzomib—Headache—Quinidine—malaria	0.00138	0.00388	CcSEcCtD
Carfilzomib—Nausea—Dapsone—malaria	0.00138	0.00388	CcSEcCtD
Carfilzomib—Diarrhoea—Quinidine barbiturate—malaria	0.00136	0.00383	CcSEcCtD
Carfilzomib—Diarrhoea—Pentoxifylline—malaria	0.00136	0.00382	CcSEcCtD
Carfilzomib—ABCB1—bone marrow—malaria	0.00135	0.00353	CbGeAlD
Carfilzomib—Nausea—Clindamycin—malaria	0.00133	0.00375	CcSEcCtD
Carfilzomib—Dizziness—Quinidine barbiturate—malaria	0.00132	0.0037	CcSEcCtD
Carfilzomib—Dizziness—Pentoxifylline—malaria	0.00131	0.00369	CcSEcCtD
Carfilzomib—Nausea—Quinidine—malaria	0.00131	0.00368	CcSEcCtD
Carfilzomib—Nausea—Quinine—malaria	0.00131	0.00368	CcSEcCtD
Carfilzomib—Vomiting—Quinidine barbiturate—malaria	0.00126	0.00356	CcSEcCtD
Carfilzomib—Vomiting—Pentoxifylline—malaria	0.00126	0.00355	CcSEcCtD
Carfilzomib—Headache—Quinidine barbiturate—malaria	0.00125	0.0035	CcSEcCtD
Carfilzomib—Headache—Pentoxifylline—malaria	0.00124	0.0035	CcSEcCtD
Carfilzomib—Nausea—Quinidine barbiturate—malaria	0.00118	0.00332	CcSEcCtD
Carfilzomib—Nausea—Pentoxifylline—malaria	0.00118	0.00332	CcSEcCtD
Carfilzomib—ABCB1—liver—malaria	0.00109	0.00286	CbGeAlD
Carfilzomib—ABCB1—brain—malaria	0.000867	0.00227	CbGeAlD
Carfilzomib—PSMB8—Disease—PKLR—malaria	0.000481	0.00184	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—G6PD—malaria	0.00048	0.00184	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD40LG—malaria	0.00048	0.00183	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—G6PD—malaria	0.000478	0.00183	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD8A—malaria	0.000477	0.00182	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ACKR1—malaria	0.000475	0.00182	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD8A—malaria	0.000475	0.00181	CbGpPWpGaD
Carfilzomib—PSMB5—HIV Infection—CD4—malaria	0.000475	0.00181	CbGpPWpGaD
Carfilzomib—PSMB1—HIV Infection—CD4—malaria	0.000475	0.00181	CbGpPWpGaD
Carfilzomib—PSMB2—HIV Infection—CD4—malaria	0.000475	0.00181	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FCGR2A—malaria	0.000474	0.00181	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ACKR1—malaria	0.000473	0.00181	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FCGR2A—malaria	0.000472	0.0018	CbGpPWpGaD
Carfilzomib—PSMB8—HIV Infection—CD4—malaria	0.000468	0.00179	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—HLA-B—malaria	0.000459	0.00175	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—HBB—malaria	0.000458	0.00175	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—HBB—malaria	0.000458	0.00175	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—HBB—malaria	0.000458	0.00175	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—HLA-B—malaria	0.000457	0.00175	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—HBB—malaria	0.000452	0.00173	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD36—malaria	0.00045	0.00172	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TLR9—malaria	0.000449	0.00172	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TLR9—malaria	0.000449	0.00172	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TLR9—malaria	0.000449	0.00172	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD36—malaria	0.000448	0.00171	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TLR9—malaria	0.000443	0.00169	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000439	0.00168	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—G6PD—malaria	0.000435	0.00166	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—G6PD—malaria	0.000435	0.00166	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—G6PD—malaria	0.000435	0.00166	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—G6PD—malaria	0.000429	0.00164	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TNF—malaria	0.000415	0.00158	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TNF—malaria	0.000415	0.00158	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TNF—malaria	0.000415	0.00158	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TNF—malaria	0.000409	0.00156	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PKLR—malaria	0.000408	0.00156	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PKLR—malaria	0.000408	0.00156	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PKLR—malaria	0.000408	0.00156	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—DHFR—malaria	0.000406	0.00155	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—DHFR—malaria	0.000404	0.00154	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PKLR—malaria	0.000403	0.00154	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IFNG—malaria	0.000394	0.0015	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TLR9—malaria	0.000383	0.00146	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TLR9—malaria	0.000381	0.00146	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ICAM1—malaria	0.000373	0.00142	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ICAM1—malaria	0.000371	0.00142	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—HPGDS—malaria	0.000366	0.0014	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD40LG—malaria	0.000366	0.0014	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD40LG—malaria	0.000366	0.0014	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD40LG—malaria	0.000366	0.0014	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—HPGDS—malaria	0.000365	0.00139	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—G6PD—malaria	0.000364	0.00139	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—G6PD—malaria	0.000364	0.00139	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—G6PD—malaria	0.000364	0.00139	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD8A—malaria	0.000362	0.00138	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD8A—malaria	0.000362	0.00138	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD8A—malaria	0.000362	0.00138	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD40LG—malaria	0.000361	0.00138	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ACKR1—malaria	0.00036	0.00138	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ACKR1—malaria	0.00036	0.00138	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ACKR1—malaria	0.00036	0.00138	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FCGR2A—malaria	0.000359	0.00137	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FCGR2A—malaria	0.000359	0.00137	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FCGR2A—malaria	0.000359	0.00137	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—G6PD—malaria	0.000359	0.00137	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD8A—malaria	0.000357	0.00136	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ACKR1—malaria	0.000355	0.00136	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FCGR2A—malaria	0.000354	0.00135	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL1B—malaria	0.000351	0.00134	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL2—malaria	0.00035	0.00134	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—HLA-B—malaria	0.000348	0.00133	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—HLA-B—malaria	0.000348	0.00133	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—HLA-B—malaria	0.000348	0.00133	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—HLA-B—malaria	0.000343	0.00131	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD36—malaria	0.000341	0.0013	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD36—malaria	0.000341	0.0013	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD36—malaria	0.000341	0.0013	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—DHFR—malaria	0.00034	0.0013	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000339	0.00129	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—DHFR—malaria	0.000338	0.00129	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—SCARB1—malaria	0.000336	0.00128	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD36—malaria	0.000336	0.00128	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—SCARB1—malaria	0.000335	0.00128	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IFNG—malaria	0.000323	0.00124	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—DHFR—malaria	0.000308	0.00117	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—DHFR—malaria	0.000308	0.00117	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—DHFR—malaria	0.000308	0.00117	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—DHFR—malaria	0.000303	0.00116	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL18—malaria	0.000294	0.00112	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD40LG—malaria	0.000293	0.00112	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL18—malaria	0.000292	0.00112	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD40LG—malaria	0.000291	0.00111	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TLR9—malaria	0.00029	0.00111	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TLR9—malaria	0.00029	0.00111	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TLR9—malaria	0.00029	0.00111	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD8A—malaria	0.000289	0.00111	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL1B—malaria	0.000288	0.0011	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD8A—malaria	0.000288	0.0011	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL2—malaria	0.000287	0.0011	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TLR9—malaria	0.000286	0.00109	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ICAM1—malaria	0.000283	0.00108	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ICAM1—malaria	0.000283	0.00108	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ICAM1—malaria	0.000283	0.00108	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ICAM1—malaria	0.000279	0.00106	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—HLA-B—malaria	0.000278	0.00106	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—HPGDS—malaria	0.000278	0.00106	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—HPGDS—malaria	0.000278	0.00106	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—HPGDS—malaria	0.000278	0.00106	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—HLA-B—malaria	0.000277	0.00106	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD4—malaria	0.000274	0.00105	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—HPGDS—malaria	0.000274	0.00105	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD36—malaria	0.000273	0.00104	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD4—malaria	0.000273	0.00104	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD36—malaria	0.000272	0.00104	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—DHFR—malaria	0.000258	0.000984	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—DHFR—malaria	0.000258	0.000984	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—DHFR—malaria	0.000258	0.000984	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—SCARB1—malaria	0.000255	0.000974	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—SCARB1—malaria	0.000255	0.000974	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—SCARB1—malaria	0.000255	0.000974	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—DHFR—malaria	0.000254	0.00097	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—SCARB1—malaria	0.000251	0.00096	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CRP—malaria	0.000246	0.00094	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CRP—malaria	0.000245	0.000936	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000243	0.000929	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—TLR4—malaria	0.000236	0.000901	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—TLR4—malaria	0.000235	0.000897	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ICAM1—malaria	0.000226	0.000864	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ICAM1—malaria	0.000225	0.00086	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL18—malaria	0.000223	0.000851	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL18—malaria	0.000223	0.000851	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL18—malaria	0.000223	0.000851	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD40LG—malaria	0.000222	0.000847	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD40LG—malaria	0.000222	0.000847	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD40LG—malaria	0.000222	0.000847	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL18—malaria	0.00022	0.000839	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD8A—malaria	0.000219	0.000838	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD8A—malaria	0.000219	0.000838	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD8A—malaria	0.000219	0.000838	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD40LG—malaria	0.000219	0.000836	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD8A—malaria	0.000216	0.000826	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CD36—malaria	0.000211	0.000806	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-B—malaria	0.000211	0.000806	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-B—malaria	0.000211	0.000806	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-B—malaria	0.000211	0.000806	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CD36—malaria	0.00021	0.000803	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—malaria	0.000209	0.0008	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-B—malaria	0.000208	0.000795	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD4—malaria	0.000208	0.000794	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD4—malaria	0.000208	0.000794	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD4—malaria	0.000208	0.000794	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NOS2—malaria	0.000207	0.000792	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD36—malaria	0.000207	0.00079	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD36—malaria	0.000207	0.00079	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD36—malaria	0.000207	0.00079	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NOS2—malaria	0.000206	0.000788	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL6—malaria	0.000206	0.000786	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD4—malaria	0.000205	0.000782	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD36—malaria	0.000204	0.000779	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CRP—malaria	0.000187	0.000713	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CRP—malaria	0.000187	0.000713	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CRP—malaria	0.000187	0.000713	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DHODH—malaria	0.000186	0.000712	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CRP—malaria	0.000184	0.000702	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TLR4—malaria	0.000179	0.000683	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TLR4—malaria	0.000179	0.000683	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TLR4—malaria	0.000179	0.000683	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TLR4—malaria	0.000176	0.000673	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IFNG—malaria	0.000172	0.000658	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ICAM1—malaria	0.000171	0.000655	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ICAM1—malaria	0.000171	0.000655	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ICAM1—malaria	0.000171	0.000655	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IFNG—malaria	0.000171	0.000654	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ICAM1—malaria	0.000169	0.000646	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD4—malaria	0.000166	0.000635	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—malaria	0.000165	0.000632	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CD36—malaria	0.00016	0.000611	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CD36—malaria	0.00016	0.000611	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CD36—malaria	0.00016	0.000611	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SLC4A1—malaria	0.000159	0.000606	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CD36—malaria	0.000158	0.000603	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NOS2—malaria	0.000157	0.0006	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NOS2—malaria	0.000157	0.0006	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NOS2—malaria	0.000157	0.0006	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NOS2—malaria	0.000155	0.000591	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL1B—malaria	0.000154	0.000587	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—malaria	0.000153	0.000586	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL2—malaria	0.000153	0.000584	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL1B—malaria	0.000153	0.000584	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—malaria	0.000153	0.000584	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—KDR—malaria	0.000153	0.000583	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL2—malaria	0.000152	0.000582	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—KDR—malaria	0.000152	0.00058	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DECR1—malaria	0.000149	0.00057	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HBB—malaria	0.000135	0.000515	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—malaria	0.00013	0.000498	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—malaria	0.00013	0.000498	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—malaria	0.00013	0.000498	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—malaria	0.000129	0.000491	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—malaria	0.000126	0.000481	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—malaria	0.000126	0.000481	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—malaria	0.000126	0.000481	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—malaria	0.000124	0.000475	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PKLR—malaria	0.00012	0.000459	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—malaria	0.000116	0.000445	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—malaria	0.000116	0.000445	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—malaria	0.000116	0.000445	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—malaria	0.000116	0.000444	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—malaria	0.000116	0.000444	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—malaria	0.000116	0.000444	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—malaria	0.000116	0.000443	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—malaria	0.000116	0.000443	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—malaria	0.000116	0.000443	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—KDR—malaria	0.000116	0.000442	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KDR—malaria	0.000116	0.000442	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KDR—malaria	0.000116	0.000442	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—malaria	0.000115	0.000438	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—malaria	0.000115	0.000438	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—malaria	0.000114	0.000437	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KDR—malaria	0.000114	0.000435	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—G6PD—malaria	0.000107	0.000409	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000103	0.000395	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—malaria	9.89e-05	0.000378	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—malaria	9.84e-05	0.000376	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—malaria	8.99e-05	0.000343	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—malaria	8.95e-05	0.000342	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—malaria	8.3e-05	0.000317	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—malaria	8.26e-05	0.000316	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—HPGDS—malaria	8.17e-05	0.000312	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DHFR—malaria	7.58e-05	0.000289	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SCARB1—malaria	7.5e-05	0.000286	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—malaria	7.49e-05	0.000286	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—malaria	7.49e-05	0.000286	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—malaria	7.49e-05	0.000286	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—malaria	7.39e-05	0.000282	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—malaria	6.81e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—malaria	6.81e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—malaria	6.81e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—malaria	6.72e-05	0.000257	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—malaria	6.29e-05	0.00024	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—malaria	6.29e-05	0.00024	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—malaria	6.29e-05	0.00024	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—malaria	6.2e-05	0.000237	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—malaria	5.81e-05	0.000222	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—malaria	5.78e-05	0.000221	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CD36—malaria	4.71e-05	0.00018	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—malaria	4.4e-05	0.000168	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—malaria	4.4e-05	0.000168	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—malaria	4.4e-05	0.000168	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—malaria	4.34e-05	0.000166	CbGpPWpGaD
